> The findings were somewhat lackluster: it found that the psychedelic was only marginally better than traditional treatments at relieving depression. This is

> The findings were somewhat lackluster: it found that the psychedelic was only marginally better than traditional treatments at relieving depression. This is said early on. But then the article continues and the gist is that it's still early days for psychedelics. That is, they compared well tested therapies with a new one (i.e., it's possible the dosage isn't optimized yet). Given that psychedelics have been around much longer, then it's actually the newer (propriety Big Pharma) therapies that are coming up short.